BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Subscribe to see BiVACOR Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BiVACOR Inc. is a medical devices company headquartered in United States, founded in 2008. It has raised at least $24M across the 2 funding rounds on record. Its most recent funding round raised $9M in July 2024. Xcout tracks 2 named people at BiVACOR Inc., including William Cohn (Chief Medical Officer). Xcout recorded 3 job postings from BiVACOR Inc. in the last 90 days.
At least $24M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $9M | — | |
| SEC Form D filing | $15M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 3 job postings from BiVACOR Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see BiVACOR Inc.'s hiring signals →
A few of BiVACOR Inc.'s closest competitors — see the full list of competitors and alternatives →
Corvion Inc., formerly known as EverHeart Systems, is headquartered in Webster, Texas, and develops fully implanted mechanical circulatory support devices. Its flagship product, the Corvion LVAD, is designed to serve as a successful circulatory support device for severe heart failure.
Procyrion, Inc. is a Houston, Texas-based heart pump developer. The company focuses on the research, expansion, and development of its Aortix circulatory support device for investigational use.
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.
V-Wave is a medical technology company established in Israel in 2009 that develops percutaneous implantable shunts and technologies for patients with chronic heart failure.
AtaCor Medical is a medical-device company developing extravascular cardiac pacing technology, including a temporary pacing system designed to deliver pacing without placing leads inside the heart or bloodstream. Its technology is intended for patients who need temporary cardiac pacing, including in post-surgical and other acute-care settings.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about BiVACOR Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.